EZRMCP2
Rat/Mouse C-Peptide 2 ELISA Kit
measures and quantifies C-Peptide 2 levels in 20 μL serum or plasma
别名:
C-Peptide 2
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12161503
eCl@ss:
32161000
NACRES:
NA.32
Input:
sample type plasma (K2 EDTA)
sample type serum
sample type serum
Assay range:
accuracy: 86-87%
(Mouse Serum), accuracy: 88-92%
(Rat Serum), accuracy: 93-95%
(Rat Plasma), linearity: 86-108%, standard curve range: 25-1600 pM
(Mouse Serum), accuracy: 88-92%
(Rat Serum), accuracy: 93-95%
(Rat Plasma), linearity: 86-108%, standard curve range: 25-1600 pM
Species reactivity:
mouse, rat
Storage temp.:
2-8°C
Shipped in:
wet ice
产品名称
大鼠/小鼠C-肽2 ELISA, This Rat/Mouse C-Peptide 2 ELISA is used to measure & quantify C-Peptide 2 levels in Metabolism & Endocrine & Neuroscience research.
species reactivity
mouse, rat
packaging
kit of 1 × 96 wells
parameter
20 μL sample volume (4hr assay)
assay range
accuracy: 86-87%
(Mouse Serum), accuracy: 88-92%
(Rat Serum), accuracy: 93-95%
(Rat Plasma), linearity: 86-108%, standard curve range: 25-1600 pM
technique(s)
ELISA: suitable
input
sample type plasma (K2 EDTA)
sample type serum
application(s)
research use
detection method
colorimetric (450nm/590nm)
shipped in
wet ice
storage temp.
2-8°C
Quality Level
General description
C肽的测定显示胰腺β-细胞功能。与内源胰岛素相比，该产品是以更稳定的速度分泌，分泌时间更长。C肽水平的检测有助于糖尿病的诊断和管理。C肽水平决定了糖尿病类型和患病时间长短。
Application
大鼠/小鼠C肽 2 ELISA 已用于体内实验以测定小鼠血液、血清和血浆中的C肽水平。
Features and Benefits
每个试剂盒足以测量39份未知样本，一式两份。
Disclaimer
仅供研究使用。不用于诊断操作。
signalword
Warning
hcodes
Hazard Classifications
Met. Corr. 1 - Skin Sens. 1
存储类别
8A - Combustible corrosive hazardous materials
Emma Leighton et al.
Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(3), 475-487 (2017-05-10)
C-peptide is a widely used measure of pancreatic beta cell function. It is produced in equimolar amounts to endogenous insulin but is excreted at a more constant rate over a longer time. Methods of estimation include urinary and unstimulated and
Jean Franciesco Vettorazzi et al.
Scientific reports, 7(1), 14876-14876 (2017-11-03)
Disruption of insulin secretion and clearance both contribute to obesity-induced hyperinsulinemia, though reduced insulin clearance seems to be the main factor. The liver is the major site for insulin degradation, a process mainly coordinated by the insulin-degrading enzyme (IDE). The
Binhai Ren et al.
The journal of gene medicine, 20(5), e3017-e3017 (2018-03-27)
Gene therapy is one treatment that may ultimately cure type 1 diabetes. We have previously shown that the introduction of furin-cleavable human insulin (INS-FUR) to the livers in several animal models of diabetes resulted in the reversal of diabetes and
Samraa H Abdel-Kawi et al.
Stem cells international, 2022, 6342594-6342594 (2022-04-23)
Stem cell transplantation is a promising therapeutic technique for the treatment of a variety of diseases; nevertheless, stem cell therapy may not always work as well as it could. The goal of this study was to test the hypothesis that
Hana Vakili et al.
The Journal of clinical investigation, 124(11), 5002-5012 (2014-10-09)
Levels of pituitary growth hormone (GH), a metabolic homeostatic factor with strong lipolytic activity, are decreased in obese individuals. GH declines prior to the onset of weight gain in response to excess caloric intake and hyperinsulinemia; however, the mechanism by
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持